CTS CORP (CTS) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CTS • US1265011056

53.83 USD
+0.55 (+1.03%)
At close: Feb 4, 2026
53.83 USD
0 (0%)
After Hours: 2/4/2026, 4:15:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CTS. CTS was compared to 123 industry peers in the Electronic Equipment, Instruments & Components industry. CTS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CTS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year CTS was profitable.
  • In the past year CTS had a positive cash flow from operations.
  • Of the past 5 years CTS 4 years were profitable.
  • Each year in the past 5 years CTS had a positive operating cash flow.
CTS Yearly Net Income VS EBIT VS OCF VS FCFCTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • The Return On Assets of CTS (7.49%) is better than 86.18% of its industry peers.
  • CTS has a Return On Equity of 10.81%. This is in the better half of the industry: CTS outperforms 73.17% of its industry peers.
  • The Return On Invested Capital of CTS (9.58%) is better than 83.74% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CTS is in line with the industry average of 8.89%.
Industry RankSector Rank
ROA 7.49%
ROE 10.81%
ROIC 9.58%
ROA(3y)7.9%
ROA(5y)4.59%
ROE(3y)11.4%
ROE(5y)6.67%
ROIC(3y)10.61%
ROIC(5y)10.13%
CTS Yearly ROA, ROE, ROICCTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • CTS's Profit Margin of 11.14% is amongst the best of the industry. CTS outperforms 86.18% of its industry peers.
  • CTS's Profit Margin has improved in the last couple of years.
  • The Operating Margin of CTS (15.25%) is better than 88.62% of its industry peers.
  • In the last couple of years the Operating Margin of CTS has grown nicely.
  • CTS's Gross Margin of 38.05% is fine compared to the rest of the industry. CTS outperforms 63.41% of its industry peers.
  • In the last couple of years the Gross Margin of CTS has grown nicely.
Industry RankSector Rank
OM 15.25%
PM (TTM) 11.14%
GM 38.05%
OM growth 3Y-0.48%
OM growth 5Y2.89%
PM growth 3YN/A
PM growth 5Y7.92%
GM growth 3Y0.63%
GM growth 5Y1.76%
CTS Yearly Profit, Operating, Gross MarginsCTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CTS is destroying value.
  • CTS has less shares outstanding than it did 1 year ago.
  • CTS has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CTS has a worse debt to assets ratio.
CTS Yearly Shares OutstandingCTS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CTS Yearly Total Debt VS Total AssetsCTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • CTS has an Altman-Z score of 6.33. This indicates that CTS is financially healthy and has little risk of bankruptcy at the moment.
  • CTS has a Altman-Z score of 6.33. This is amongst the best in the industry. CTS outperforms 80.49% of its industry peers.
  • The Debt to FCF ratio of CTS is 1.13, which is an excellent value as it means it would take CTS, only 1.13 years of fcf income to pay off all of its debts.
  • CTS has a better Debt to FCF ratio (1.13) than 82.93% of its industry peers.
  • A Debt/Equity ratio of 0.17 indicates that CTS is not too dependend on debt financing.
  • CTS has a Debt to Equity ratio (0.17) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.13
Altman-Z 6.33
ROIC/WACC0.63
WACC15.32%
CTS Yearly LT Debt VS Equity VS FCFCTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

  • CTS has a Current Ratio of 2.64. This indicates that CTS is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of CTS (2.64) is comparable to the rest of the industry.
  • A Quick Ratio of 2.12 indicates that CTS has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.12, CTS is in the better half of the industry, outperforming 62.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 2.12
CTS Yearly Current Assets VS Current LiabilitesCTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.42% over the past year.
  • The Earnings Per Share has been growing by 8.40% on average over the past years. This is quite good.
  • CTS shows a small growth in Revenue. In the last year, the Revenue has grown by 3.60%.
  • CTS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.92% yearly.
EPS 1Y (TTM)1.42%
EPS 3Y3.98%
EPS 5Y8.4%
EPS Q2Q%-4.76%
Revenue 1Y (TTM)3.6%
Revenue growth 3Y0.18%
Revenue growth 5Y1.92%
Sales Q2Q%7.96%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.56% on average over the next years.
  • The Revenue is expected to grow by 4.20% on average over the next years.
EPS Next Y2.86%
EPS Next 2Y5.69%
EPS Next 3Y6.56%
EPS Next 5YN/A
Revenue Next Year3.61%
Revenue Next 2Y3.8%
Revenue Next 3Y4.2%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CTS Yearly Revenue VS EstimatesCTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CTS Yearly EPS VS EstimatesCTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

  • CTS is valuated quite expensively with a Price/Earnings ratio of 25.15.
  • CTS's Price/Earnings ratio is a bit cheaper when compared to the industry. CTS is cheaper than 72.36% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CTS to the average of the S&P500 Index (28.25), we can say CTS is valued inline with the index average.
  • Based on the Price/Forward Earnings ratio of 22.21, the valuation of CTS can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, CTS is valued a bit cheaper than 71.54% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CTS to the average of the S&P500 Index (27.50), we can say CTS is valued inline with the index average.
Industry RankSector Rank
PE 25.15
Fwd PE 22.21
CTS Price Earnings VS Forward Price EarningsCTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CTS is valued a bit cheaper than 78.86% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CTS indicates a rather cheap valuation: CTS is cheaper than 84.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.5
EV/EBITDA 13.27
CTS Per share dataCTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of CTS may justify a higher PE ratio.
PEG (NY)8.79
PEG (5Y)3
EPS Next 2Y5.69%
EPS Next 3Y6.56%

6

5. Dividend

5.1 Amount

  • CTS has a yearly dividend return of 0.31%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.46, CTS pays a better dividend. On top of this CTS pays more dividend than 81.30% of the companies listed in the same industry.
  • With a Dividend Yield of 0.31, CTS pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.31%

5.2 History

  • The dividend of CTS has a limited annual growth rate of 0.16%.
  • CTS has paid a dividend for at least 10 years, which is a reliable track record.
  • CTS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.16%
Div Incr Years0
Div Non Decr Years31
CTS Yearly Dividends per shareCTS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • 8.09% of the earnings are spent on dividend by CTS. This is a low number and sustainable payout ratio.
  • CTS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP8.09%
EPS Next 2Y5.69%
EPS Next 3Y6.56%
CTS Yearly Income VS Free CF VS DividendCTS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M
CTS Dividend Payout.CTS Dividend Payout, showing the Payout Ratio.CTS Dividend Payout.PayoutRetained Earnings

CTS CORP

NYSE:CTS (2/4/2026, 4:15:00 PM)

After market: 53.83 0 (0%)

53.83

+0.55 (+1.03%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-28
Earnings (Next)02-10
Inst Owners98.86%
Inst Owner Change-1.7%
Ins Owners2.27%
Ins Owner Change1.45%
Market Cap1.56B
Revenue(TTM)531.48M
Net Income(TTM)59.19M
Analysts45
Price Target47.94 (-10.94%)
Short Float %1.36%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield 0.31%
Yearly Dividend0.16
Dividend Growth(5Y)0.16%
DP8.09%
Div Incr Years0
Div Non Decr Years31
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0%
Min EPS beat(2)-2.61%
Max EPS beat(2)2.61%
EPS beat(4)1
Avg EPS beat(4)-3.48%
Min EPS beat(4)-11.09%
Max EPS beat(4)2.61%
EPS beat(8)5
Avg EPS beat(8)1.64%
EPS beat(12)7
Avg EPS beat(12)1.48%
EPS beat(16)10
Avg EPS beat(16)2.79%
Revenue beat(2)2
Avg Revenue beat(2)2.39%
Min Revenue beat(2)0.99%
Max Revenue beat(2)3.78%
Revenue beat(4)2
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-4.99%
Max Revenue beat(4)3.78%
Revenue beat(8)2
Avg Revenue beat(8)-1.31%
Revenue beat(12)3
Avg Revenue beat(12)-1.88%
Revenue beat(16)7
Avg Revenue beat(16)-0.34%
PT rev (1m)0%
PT rev (3m)9.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.64%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.75%
Valuation
Industry RankSector Rank
PE 25.15
Fwd PE 22.21
P/S 2.94
P/FCF 19.5
P/OCF 15.82
P/B 2.86
P/tB 8.55
EV/EBITDA 13.27
EPS(TTM)2.14
EY3.98%
EPS(NY)2.42
Fwd EY4.5%
FCF(TTM)2.76
FCFY5.13%
OCF(TTM)3.4
OCFY6.32%
SpS18.3
BVpS18.85
TBVpS6.3
PEG (NY)8.79
PEG (5Y)3
Graham Number30.13
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 10.81%
ROCE 11.82%
ROIC 9.58%
ROICexc 11.42%
ROICexgc 31.19%
OM 15.25%
PM (TTM) 11.14%
GM 38.05%
FCFM 15.09%
ROA(3y)7.9%
ROA(5y)4.59%
ROE(3y)11.4%
ROE(5y)6.67%
ROIC(3y)10.61%
ROIC(5y)10.13%
ROICexc(3y)13.62%
ROICexc(5y)13.04%
ROICexgc(3y)31.83%
ROICexgc(5y)27.79%
ROCE(3y)13.09%
ROCE(5y)12.49%
ROICexgc growth 3Y2.59%
ROICexgc growth 5Y8.96%
ROICexc growth 3Y-10.96%
ROICexc growth 5Y-0.3%
OM growth 3Y-0.48%
OM growth 5Y2.89%
PM growth 3YN/A
PM growth 5Y7.92%
GM growth 3Y0.63%
GM growth 5Y1.76%
F-Score8
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.13
Debt/EBITDA 0.79
Cap/Depr 54.58%
Cap/Sales 3.51%
Interest Coverage 17.38
Cash Conversion 85.82%
Profit Quality 135.51%
Current Ratio 2.64
Quick Ratio 2.12
Altman-Z 6.33
F-Score8
WACC15.32%
ROIC/WACC0.63
Cap/Depr(3y)53.27%
Cap/Depr(5y)54.74%
Cap/Sales(3y)2.91%
Cap/Sales(5y)3.06%
Profit Quality(3y)146.84%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.42%
EPS 3Y3.98%
EPS 5Y8.4%
EPS Q2Q%-4.76%
EPS Next Y2.86%
EPS Next 2Y5.69%
EPS Next 3Y6.56%
EPS Next 5YN/A
Revenue 1Y (TTM)3.6%
Revenue growth 3Y0.18%
Revenue growth 5Y1.92%
Sales Q2Q%7.96%
Revenue Next Year3.61%
Revenue Next 2Y3.8%
Revenue Next 3Y4.2%
Revenue Next 5YN/A
EBIT growth 1Y6.45%
EBIT growth 3Y-0.29%
EBIT growth 5Y4.86%
EBIT Next Year36.69%
EBIT Next 3Y15%
EBIT Next 5YN/A
FCF growth 1Y21.72%
FCF growth 3Y4.58%
FCF growth 5Y13.56%
OCF growth 1Y20.25%
OCF growth 3Y4.85%
OCF growth 5Y9.04%

CTS CORP / CTS FAQ

What is the ChartMill fundamental rating of CTS CORP (CTS) stock?

ChartMill assigns a fundamental rating of 7 / 10 to CTS.


Can you provide the valuation status for CTS CORP?

ChartMill assigns a valuation rating of 5 / 10 to CTS CORP (CTS). This can be considered as Fairly Valued.


How profitable is CTS CORP (CTS) stock?

CTS CORP (CTS) has a profitability rating of 8 / 10.


Can you provide the financial health for CTS stock?

The financial health rating of CTS CORP (CTS) is 8 / 10.


Can you provide the dividend sustainability for CTS stock?

The dividend rating of CTS CORP (CTS) is 6 / 10 and the dividend payout ratio is 8.09%.